Affiliation: Roche Pharma Research and Early Development, F.Hoffmann-La Roche Ltd, Grenzacherstrasse 124 4070 Basel, Switzerland

I received a Bachelor’s degree in Biological Sciences in 2008 and an MS in Molecular Biology in 2010 at the University of Milano-Bicocca, Italy. During that period, my research focused on mechanisms of gene expression and pre-mRNA splicing as they relate to neurodegenerative diseases. I obtained my PhD degree in Molecular Biology and Biochemistry in 2015 from the University of Bern-Switzerland, for studies related to cell cycle regulation and 3’end processing of mRNAs. In 2015 I moved to San Francisco-California and joined Genentech Inc. as a postdoctoral fellow in the Department of Research Pathology where I dedicated my research to (i) investigate the effect of combination therapy on human primary NK cells activation and signaling pathways and (ii) develop a method for in situ ISH-ICC on paucicellular specimens for biomarker detection. Between 2018 and 2020 I undertook a second postdoc in the Departments of Cancer Immunology and Molecular Biology at Genentech Inc. where I contributed to the development of mRNA-based cancer vaccines for personalized therapy and the understanding of their mechanisms of action. Currently, I am a Senior Scientist in Roche, Lead Discovery.